113 related articles for article (PubMed ID: 25973481)
1. Concise synthesis of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine starting with bufotenine from Brazilian Anadenanthera ssp.
Moreira LA; Murta MM; Gatto CC; Fagg CW; dos Santos ML
Nat Prod Commun; 2015 Apr; 10(4):581-4. PubMed ID: 25973481
[TBL] [Abstract][Full Text] [Related]
2. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
[TBL] [Abstract][Full Text] [Related]
3. 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions.
Takahashi T; Takahashi K; Ido T; Yanai K; Iwata R; Ishiwata K; Nozoe S
Int J Appl Radiat Isot; 1985 Dec; 36(12):965-9. PubMed ID: 3866749
[TBL] [Abstract][Full Text] [Related]
4. The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified.
Mishraki-Berkowitz T; Kochelski E; Kavanagh P; O'Brien J; Dunne C; Talbot B; Ennis P; Wolf UE
J Forensic Sci; 2020 Sep; 65(5):1450-1457. PubMed ID: 32374425
[TBL] [Abstract][Full Text] [Related]
5. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.
Kärkkäinen J; Forsström T; Tornaeus J; Wähälä K; Kiuru P; Honkanen A; Stenman UH; Turpeinen U; Hesso A
Scand J Clin Lab Invest; 2005; 65(3):189-99. PubMed ID: 16095048
[TBL] [Abstract][Full Text] [Related]
6. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.
Barker SA; McIlhenny EH; Strassman R
Drug Test Anal; 2012; 4(7-8):617-35. PubMed ID: 22371425
[TBL] [Abstract][Full Text] [Related]
7. Pharmañopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine.
Ott J
J Psychoactive Drugs; 2001; 33(3):273-81. PubMed ID: 11718320
[TBL] [Abstract][Full Text] [Related]
8. Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
Forsström T; Tuominen J; Karkkäinen J
Scand J Clin Lab Invest; 2001; 61(7):547-56. PubMed ID: 11763413
[TBL] [Abstract][Full Text] [Related]
9. Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies.
Sitaram BR; McLeod WR
Biol Psychiatry; 1990 Nov; 28(10):841-8. PubMed ID: 2268688
[TBL] [Abstract][Full Text] [Related]
10. Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine.
Räisänen M; Kärkkäinen J
J Chromatogr; 1979 Apr; 162(4):579-84. PubMed ID: 118980
[No Abstract] [Full Text] [Related]
11. Citrus genus plants contain N-methylated tryptamine derivatives and their 5-hydroxylated forms.
Servillo L; Giovane A; Balestrieri ML; Casale R; Cautela D; Castaldo D
J Agric Food Chem; 2013 May; 61(21):5156-62. PubMed ID: 23682903
[TBL] [Abstract][Full Text] [Related]
12. [Studies on constituents of rootsanel leaves from Desmodium blandum and their cytotoxic activity against growth of several tumor cells].
Gan N; Yang X; Li TH; He P
Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2077-80. PubMed ID: 19160788
[TBL] [Abstract][Full Text] [Related]
13. Indolealkylamines and prolactin secretion. A structure-activity study in the central nervous system of the rat.
Seeman G; Brown GM
Neuropharmacology; 1985 Dec; 24(12):1195-200. PubMed ID: 3867833
[TBL] [Abstract][Full Text] [Related]
14. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method.
Barker SA; Littlefield-Chabaud MA; David C
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):37-47. PubMed ID: 11232854
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic behavior of bufotenine and bufotenine N-oxide: Solvent and pH effects and interaction with biomembrane models.
Almeida E Silva G; Galvão Wakui V; Kato L; Marquezin CA
Biochim Biophys Acta Biomembr; 2024 Apr; 1866(4):184304. PubMed ID: 38408695
[TBL] [Abstract][Full Text] [Related]
16. Interaction of psychedelic tryptamine derivatives with a lipid bilayer.
Zohairi F; Khandelia H; Hakami Zanjani AA
Chem Phys Lipids; 2023 Mar; 251():105279. PubMed ID: 36627076
[TBL] [Abstract][Full Text] [Related]
17. Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.
Shen HW; Jiang XL; Winter JC; Yu AM
Curr Drug Metab; 2010 Oct; 11(8):659-66. PubMed ID: 20942780
[TBL] [Abstract][Full Text] [Related]
18. Chemical Characterization and Molecular Dynamics Simulations of Bufotenine by Surface-Enhanced Raman Scattering (SERS) and Density Functional Theory (DFT).
Wu X; Cañamares MV; Kakoulli I; Sanchez-Cortes S
J Phys Chem Lett; 2022 Jun; 13(25):5831-5837. PubMed ID: 35726975
[TBL] [Abstract][Full Text] [Related]
19. Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study.
Shen HW; Jiang XL; Yu AM
Bioanalysis; 2009 Apr; 1(1):87-95. PubMed ID: 20523750
[TBL] [Abstract][Full Text] [Related]
20. Bufotenine esters.
Glennon RA; Gessner PK; Godse DD; Kline BJ
J Med Chem; 1979 Nov; 22(11):1414-6. PubMed ID: 533890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
